Belén Rubio-Ruiz

About Belén Rubio-Ruiz

Belén Rubio-Ruiz, With an exceptional h-index of 19 and a recent h-index of 16 (since 2020), a distinguished researcher at Universidad de Granada, specializes in the field of Medicinal Chemistry, Chemical Biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

N-aryltetrahydroisoquinoline derivatives as HA-CD44 interaction inhibitors: Design, synthesis, computational studies, and antitumor effect

New amidine-benzenesulfonamides as iNOS inhibitors for the therapy of the triple negative breast cancer

In Cellulo Bioorthogonal Catalysis by Encapsulated AuPd Nanoalloys: Overcoming Intracellular Deactivation

New Drug Modalities in Medicinal Chemistry, Pharmacology, and Translational Science

Supporting Information for In cellulo bioorthogonal catalysis by encapsulated AuPd nanoalloys: Overcoming intracellular deactivation

Utilización de la red social Instagram para fomentar la práctica continuada del alumnado en la nomenclatura y formulación de compuestos orgánicos

Selective anticancer therapy based on a HA-CD44 interaction inhibitor loaded on polymeric nanoparticles

A 5-FU Precursor Designed to Evade Anabolic and Catabolic Drug Pathways and Activated by Pd Chemistry In Vitro and In Vivo

Belén Rubio-Ruiz Information

University

Position

Departamento de Química Farmacéutica y Orgánica

Citations(all)

1433

Citations(since 2020)

1132

Cited By

723

hIndex(all)

19

hIndex(since 2020)

16

i10Index(all)

26

i10Index(since 2020)

23

Email

University Profile Page

Google Scholar

Belén Rubio-Ruiz Skills & Research Interests

Medicinal Chemistry

Chemical Biology

Top articles of Belén Rubio-Ruiz

N-aryltetrahydroisoquinoline derivatives as HA-CD44 interaction inhibitors: Design, synthesis, computational studies, and antitumor effect

European Journal of Medicinal Chemistry

2023/10/5

Belén Rubio-Ruiz
Belén Rubio-Ruiz

H-Index: 12

Carmen Domene
Carmen Domene

H-Index: 22

New amidine-benzenesulfonamides as iNOS inhibitors for the therapy of the triple negative breast cancer

European Journal of Medicinal Chemistry

2023/2/15

Belén Rubio-Ruiz
Belén Rubio-Ruiz

H-Index: 12

In Cellulo Bioorthogonal Catalysis by Encapsulated AuPd Nanoalloys: Overcoming Intracellular Deactivation

Nano Letters

2023/1/17

Belén Rubio-Ruiz
Belén Rubio-Ruiz

H-Index: 12

New Drug Modalities in Medicinal Chemistry, Pharmacology, and Translational Science

2021/9/30

Supporting Information for In cellulo bioorthogonal catalysis by encapsulated AuPd nanoalloys: Overcoming intracellular deactivation

2023

Utilización de la red social Instagram para fomentar la práctica continuada del alumnado en la nomenclatura y formulación de compuestos orgánicos

2023

Selective anticancer therapy based on a HA-CD44 interaction inhibitor loaded on polymeric nanoparticles

Pharmaceutics

2022/4/4

Belén Rubio-Ruiz
Belén Rubio-Ruiz

H-Index: 12

Carmen Domene
Carmen Domene

H-Index: 22

A 5-FU Precursor Designed to Evade Anabolic and Catabolic Drug Pathways and Activated by Pd Chemistry In Vitro and In Vivo

Journal of Medicinal Chemistry

2022/1/3

Belén Rubio-Ruiz
Belén Rubio-Ruiz

H-Index: 12

A minimally-masked inactive prodrug of panobinostat that is bioorthogonally activated by gold chemistry

Bioorganic & Medicinal Chemistry

2021/7/1

Belén Rubio-Ruiz
Belén Rubio-Ruiz

H-Index: 12

Recent advances in the design of choline kinase α inhibitors and the molecular basis of their inhibition

2021/3

Nondestructive production of exosomes loaded with ultrathin palladium nanosheets for targeted bio-orthogonal catalysis

Nature Protocols

2021/1

Bioorthogonal compounds comprising a propargyl group for treating cancer

2020/9/17

Bioorthogonal uncaging of cytotoxic paclitaxel through Pd nanosheet–hydrogel frameworks

Journal of Medicinal Chemistry

2020/8/5

See List of Professors in Belén Rubio-Ruiz University(Universidad de Granada)

Co-Authors

academic-engine